These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37223323)
21. Heavy and light chain (AHL)-type cardiac amyloidosis: first histopathologic-proven case illustrating involvement of the heart. Sekulic M; Pichler Sekulic S; Weins A Virchows Arch; 2020 Nov; 477(5):733-738. PubMed ID: 32388718 [TBL] [Abstract][Full Text] [Related]
22. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant. Ono R; Takahashi H; Sato T; Yamazaki T; Hori Y; Fukushima K J Cardiol Cases; 2020 Nov; 22(5):221-225. PubMed ID: 33133314 [TBL] [Abstract][Full Text] [Related]
23. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis. Jung MH; Chang S; Han EJ; Youn JC Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180 [TBL] [Abstract][Full Text] [Related]
24. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult. Domingues K; Saraiva M; Marta L; Monteiro I; Leal M Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998 [TBL] [Abstract][Full Text] [Related]
25. A patient with AL amyloidosis with negative free light chain results. Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890 [TBL] [Abstract][Full Text] [Related]
26. A case report of cardiac amyloidosis presenting with chronic pericardial effusion and conduction block. John KJ; Mishra AK; Iyyadurai R Eur Heart J Case Rep; 2019 Dec; 3(4):1-7. PubMed ID: 31911988 [TBL] [Abstract][Full Text] [Related]
27. Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis. Makivic N; Stöllberger C; Nakuz T; Schneider B; Schmid C; Hasun M; Weidinger F ESC Heart Fail; 2020 Aug; 7(4):1987-1991. PubMed ID: 32515557 [TBL] [Abstract][Full Text] [Related]
28. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement. Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171 [TBL] [Abstract][Full Text] [Related]
29. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis. Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908 [TBL] [Abstract][Full Text] [Related]
30. Myocardial Scintigraphy in Diagnosing Cardiac Transthyretin Amyloidosis. Petrovic M; Lopez PD; Eng C; Rashid M Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 36006616 [TBL] [Abstract][Full Text] [Related]
31. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis. Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596 [TBL] [Abstract][Full Text] [Related]
32. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure. Molina O G; Judge D; Campbell W; Chahal H; Mugmon M J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650 [TBL] [Abstract][Full Text] [Related]